Estrogen receptor β (ERβ) level but not its ERβcx variant helps to predict tamoxifen resistance in breast cancer

Majida Esslimani-Sahla, Joelle Simony-Lafontaine, Andrew Kramar, Roselyne Lavaill, Caroline Mollevi, Margaret Warner, Jan Åke Gustafsson, Henri Rochefort

Research output: Contribution to journalArticlepeer-review

140 Scopus citations

Fingerprint

Dive into the research topics of 'Estrogen receptor β (ERβ) level but not its ERβcx variant helps to predict tamoxifen resistance in breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences